VHCP Management EG, LLC, 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), bought 161,700 shares at $9.33 ($1.5M) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Open-market purchase of $1.5M KALV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.23 | 100,000 | $923K | 61.6% |
| 2 | $9.33 | 61,700 | $576K | 38.4% |
| Total | $9.27 avg | 161,700 | $1.5M | 100% |
| Filing → |